Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
V. Macavei, K. Spurling, H. Makker (London, United Kingdom). Validation of raised serum bicarbonate for diagnosis of obesity hypoventilation syndrome. Eur Respir J 2012; 40: Suppl. 56, 3185

Member's Comments

No comment yet.

Related content which might interest you: Defining obesity hypoventilation syndrome Source: Breathe, 17 (3) 210089; 10.1183/20734735.0089-2021 Year: 2021 Relation of serum ghrelin and leptin levels to blood gases disturbance in obesity hypoventilation syndrome patients Source: Annual Congress 2009 - Noninvasive ventilation: new and old aspects Year: 2009 Elevated serum erythropoietin level in obesity hypoventilation syndrome patients improved by nasal positive pressure ventilation therapy Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002 Hypoxic challenge assessments in patients with obesity hypoventilation syndrome Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004 Grading obesity hypoventilation syndrome severity Source: Eur Respir J 2008; 32: 817-818 Year: 2008 The heart in obesity hypoventilation syndrome Source: Eur Respir Monogr 2020; 88: 143-153 Year: 2020 The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004 Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004 Nocturnal diaphragm failure in obesity hypoventilation syndrome (OHS) Source: Eur Respir J 2004; 24: Suppl. 48, 115s Year: 2004 Cardiovascular comorbidity in obesity hypoventilation syndrome: has nocturnal hypoventilation a protective effect? Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017 RANTES is specifically elevated in obesity hypoventilation syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007 Obesity hypoventilation syndrome in childhood Source: Sleep and Breathing Conference 2017 Year: 2017 Treatment strategies in obesity hypoventilation and overlap syndrome Source: Annual Congress 2010 - Challenges in sleep medicine: ventilatory failure during sleep Year: 2010 The lack of evidence based knowledge of metabolic syndrome in obesity hypoventilation syndrome Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Screening for obesity hypoventilation syndrome in bariatric patients. Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020 Association of fasting glucose and glycosylated haemoglobin levels with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Prevalence and clinical characteristics of obesity – hypoventilation syndrome in Greece Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea Year: 2008